Rocket Lab president sells 3,500 RKLB shares
Rocket Lab Corp executive Marvin Bradford Clevenger, President of Rocket Lab USA, Inc, sold 3,500 shares of Common Stock in an open-market transaction on May 28, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Rocket Lab Corp executive Marvin Bradford Clevenger, President of Rocket Lab USA, Inc, sold 3,500 shares of Common Stock in an open-market transaction on May 28, 2026. The weighted-average sale price was $146.6731 per share, across trades ranging from $146.60 to $146.78. After this sale, Clevenger directly holds 473,975 Rocket Lab shares.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 3,500 | $146.6731 | $513K |
Footnotes (1)
- F1. The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $146.6000 to $146.7800. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Key Figures
Key Terms
weighted-average price financial
open-market sale financial
Common Stock financial
Form 4 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Rocket Lab (RKLB) report for Marvin Bradford Clevenger?
What type of Rocket Lab (RKLB) insider transaction did Marvin Bradford Clevenger execute?
What does the weighted-average price mean in the Rocket Lab (RKLB) Form 4 for Marvin Bradford Clevenger?
AI-generated analysis. How Rhea-AI works. Not financial advice.